DK1317923T3 - Sammensætninger til forøgelse af vanddyrs overlevelse ved udsættelse for et RNA-virus - Google Patents

Sammensætninger til forøgelse af vanddyrs overlevelse ved udsættelse for et RNA-virus

Info

Publication number
DK1317923T3
DK1317923T3 DK02258455.1T DK02258455T DK1317923T3 DK 1317923 T3 DK1317923 T3 DK 1317923T3 DK 02258455 T DK02258455 T DK 02258455T DK 1317923 T3 DK1317923 T3 DK 1317923T3
Authority
DK
Denmark
Prior art keywords
infection
survival
bimavirus
animals
aquatic
Prior art date
Application number
DK02258455.1T
Other languages
English (en)
Inventor
Ana Maria Sandino
Geraldine Mlynarz
Original Assignee
Ana Maria Sandino
Geraldine Mlynarz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42140308&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1317923(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ana Maria Sandino, Geraldine Mlynarz filed Critical Ana Maria Sandino
Application granted granted Critical
Publication of DK1317923T3 publication Critical patent/DK1317923T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Fodder In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK02258455.1T 2001-12-07 2002-12-09 Sammensætninger til forøgelse af vanddyrs overlevelse ved udsættelse for et RNA-virus DK1317923T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33668401P 2001-12-07 2001-12-07

Publications (1)

Publication Number Publication Date
DK1317923T3 true DK1317923T3 (da) 2010-08-09

Family

ID=42140308

Family Applications (2)

Application Number Title Priority Date Filing Date
DK10000710.3T DK2193792T3 (da) 2001-12-07 2002-12-09 Neomycin til forøgelse af overlevelsesraten for vandlevende dyr, der udsættes for IPNV
DK02258455.1T DK1317923T3 (da) 2001-12-07 2002-12-09 Sammensætninger til forøgelse af vanddyrs overlevelse ved udsættelse for et RNA-virus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK10000710.3T DK2193792T3 (da) 2001-12-07 2002-12-09 Neomycin til forøgelse af overlevelsesraten for vandlevende dyr, der udsættes for IPNV

Country Status (9)

Country Link
US (2) US7652050B2 (da)
EP (2) EP2193792B1 (da)
AT (2) ATE522212T1 (da)
CA (1) CA2428703A1 (da)
CL (1) CL2008003293A1 (da)
DE (1) DE60236136D1 (da)
DK (2) DK2193792T3 (da)
ES (2) ES2372915T3 (da)
NO (2) NO20025898L (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1931204A1 (en) * 2005-08-29 2008-06-18 Novartis AG Use of oxazole derivatives for controlling fish parasites
NO20055541L (no) * 2005-11-23 2007-05-24 Berge Biomed As Use of fatty acid analogues
US8859513B2 (en) * 2010-06-08 2014-10-14 Laboratorio De Diagnostico Gam, S.A. Use of 1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide for the treatment of infectious salmon anemia
WO2013059168A2 (en) * 2011-10-21 2013-04-25 Research Development Foundation Espirito santo virus and methods for detecting and preventing infection with the same
KR101540696B1 (ko) 2014-12-12 2015-08-03 대한민국 바이러스 내성 넙치 육종 방법
AU2022422062A1 (en) * 2021-12-22 2024-07-18 Cj Cheiljedang Corporation Antiviral composition comprising nucleoside analogues derived from nucleic acid and pharmaceutically acceptable salt thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878047A (en) 1973-02-02 1975-04-15 Upjohn Co Process for production of AT-125
US4225720A (en) 1978-05-15 1980-09-30 The Upjohn Company Purification of AT-125
USRE31578E (en) 1978-05-15 1984-05-01 The Upjohn Company α(Substituted) amino-3-substituted-2-isoxazoline-5-acetic acids (esters)
US4256898A (en) 1978-05-15 1981-03-17 The Upjohn Company α(substituted) Amino-3-substituted-2-isoxazoline-5-acetic acids (esters)
US4232164A (en) 1978-05-15 1980-11-04 The Upjohn Company Purification of AT-125
JPS5793968A (en) * 1980-11-11 1982-06-11 Sankyo Co Ltd Carbamic acid ester and insecticide containing the same
US4843087A (en) * 1983-08-29 1989-06-27 Sterling Drug Inc. Di-heterocyclic compounds and their use as antiviral agents
US5087639A (en) * 1988-11-02 1992-02-11 The Upjohn Company Preventing CNS toxicity of acivicin when used with four large neutral amino acids
RU2060010C1 (ru) 1989-12-27 1996-05-20 Фудзисава Фармасьютикал Ко., Лтд. Корм для рыб
US5349068A (en) 1992-04-15 1994-09-20 Sterling Winthrop Inc. 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US20020058911A1 (en) * 1999-05-07 2002-05-16 Paul Gilson Support frame for an embolic protection device
US7037320B2 (en) * 2001-12-21 2006-05-02 Salviac Limited Support frame for an embolic protection device
US6540722B1 (en) * 1999-12-30 2003-04-01 Advanced Cardiovascular Systems, Inc. Embolic protection devices
US6689151B2 (en) * 2001-01-25 2004-02-10 Scimed Life Systems, Inc. Variable wall thickness for delivery sheath housing
US8182508B2 (en) * 2005-10-04 2012-05-22 Cook Medical Technologies Llc Embolic protection device
US20070239198A1 (en) * 2006-04-03 2007-10-11 Boston Scientific Scimed, Inc. Filter and wire with distal isolation

Also Published As

Publication number Publication date
EP1317923B1 (en) 2010-04-28
DK2193792T3 (da) 2012-01-02
NO335129B1 (no) 2014-09-22
US20030191169A1 (en) 2003-10-09
ATE522212T1 (de) 2011-09-15
ES2345244T3 (es) 2010-09-20
ATE465730T1 (de) 2010-05-15
EP2193792A1 (en) 2010-06-09
NO20110661L (no) 2003-06-10
ES2372915T3 (es) 2012-01-27
EP2193792B1 (en) 2011-08-31
CL2008003293A1 (es) 2009-03-20
NO20025898L (no) 2003-06-10
NO20025898D0 (no) 2002-12-09
EP1317923A3 (en) 2003-09-10
US20100204290A1 (en) 2010-08-12
US8044031B2 (en) 2011-10-25
US7652050B2 (en) 2010-01-26
DE60236136D1 (de) 2010-06-10
EP1317923A2 (en) 2003-06-11
CA2428703A1 (en) 2004-11-14

Similar Documents

Publication Publication Date Title
EA200800209A1 (ru) N-тиоантраниламидные соединения и их применение в качестве пестицидов
EA200500723A1 (ru) Соединения бензофурана, композиции и способы лечения и профилактики инфекций, вызванных вирусом гепатита c, и связанных с ним заболеваний
EA200900156A1 (ru) Пиридазиновое соединение (варианты), способ его получения (варианты), способ лечения или профилактики инфекционного вирусного гепатита с с его помощью, композиция и лекарственное средство на его основе
ATE358722T1 (de) Kälte-adaptierte pferde influenza-viren
EA201170969A1 (ru) Новые макроциклические ингибиторы репликации вируса гепатита с
EA200500610A1 (ru) Композиция для лечения инфекции, вызываемой вирусами семейств flaviviridae
DE602004014791D1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
EA201071034A1 (ru) Новые макроциклические ингибиторы репликаций вируса гепатита с
AR060873A1 (es) Derivados biciclicos como inhibidores de cetp
RU2010140627A (ru) Производные пирролидина
BRPI0410870A (pt) compostos trieterocìclicos, composições, e métodos para tratar cáncer ou doenças virais
CL2008003293A1 (es) Uso de neomicina para preparar un medicamento para tratar y prevenir una infección causada por un virus birnaviridae en un animal acuatico (div. sol. n°2800-02)
BRPI0507801A (pt) compostos de azetidina substituìda, processo para a preparação de compostos de azetidina substituìda, medicamento e uso de pelo menos um composto de azetidina substituìda
RU2016129272A (ru) Применение изоксазолиновых соединений на домашней птице
EA202191223A1 (ru) НОВЫЕ 6,7-ДИГИДРО-4Н-ПИРАЗОЛО[1,5-а]ПИРАЗИН-ИНДОЛ-2-КАРБОКСАМИДЫ, АКТИВНЫЕ ПРОТИВ ВИРУСА ГЕПАТИТА B (HBV)
EA200970375A1 (ru) Соединения и способы лечения вируса гепатита с
EA201000277A1 (ru) Соединения для лечения гепатита с
ATE552347T1 (de) Oligonukleotidverbindung und verfahren zur behandlung von nidovirusinfektionen
BRPI0514476A (pt) inibidores da formação de cápsideo hiv-1: aril aminometil tiazol uréias substituìdas e análogos destas
WO2001060849A3 (en) Cold-adapted equine influenza viruses
DE60030732D1 (de) Verwendung von 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol zur prävention oder behandlung viraler myocarditis
RU2004139033A (ru) Индазоламиноацетонитрильные производные, обладающие особой пестицидной активностью
ATE498398T1 (de) Cycloalkyl-heterozyklen zur behandlung des hepatitis-c-virus
BR0314640A (pt) Inibidor de vìrus de hepatite c compreendendo, como um ingrediente ativo, alfa-glicosilceramida
EA200870430A1 (ru) Внутримышечные антивирусные способы лечения